Measuring the impact of managed care plans on the use of biologics.
Furst
Daniel E
DE
D001172:Arthritis, Rheumatoid / Q000628:therapy; D001688:Biological Products / Q000627:therapeutic use*; D006801:Humans; D008329:Managed Care Programs / Q000191:economics*; D014481:United States
D001688:Biological Products